2021 ICD-10-CM Code O36.1124

Maternal care for Anti-A sensitization, second trimester, fetus 4

Version 2021
Billable Code
7th Character Code
Maternity Diagnoses
Diagnoses For Females Only
Second Trimester (14 to 27 Weeks)
MS-DRG Mapping

Valid for Submission

O36.1124 is a billable diagnosis code used to specify a medical diagnosis of maternal care for anti-a sensitization, second trimester, fetus 4. The code O36.1124 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

The code O36.1124 is applicable to female patients aged 12 through 55 years inclusive. It is clinically and virtually impossible to use this code on a non-female patient outside the stated age range.

ICD-10:O36.1124
Short Description:Maternal care for Anti-A sensitization, second tri, fetus 4
Long Description:Maternal care for Anti-A sensitization, second trimester, fetus 4

Code Classification

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

Convert O36.1124 to ICD-9 Code

The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code O36.1124 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)